OnKure Therapeutics, Inc. (OKUR) Insider Trading

Name: OnKure Therapeutics, Inc. (OKUR) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 23, 2026): Saccomano Nicholas A (President and CEO): Sale of 87 shares, $258.76.

Get alerted when insiders trade OKUR

Email address

Loading company data...

Beta

Loading company details...

Beta